Of note, this group did not find any significant difference in clinical outcomes or overall survivability of ALCL cells between p63-positive and p63-negative cases, which suggests that the expression and function of p63 are not crucial for pathogenic outcomes or cell survivability in ALCL as they are in other cancers. The gene discussed is TP63; the disease is cancer.